A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome

MA Teriaca; M Loi; Mustafa Suker; Ferry Eskens; Casper van Eijck; J.J.M.E. Nuyttens

doi:10.1016/j.radonc.2020.11.006

A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome

MA Teriaca
, M Loi
, Mustafa Suker
, Ferry Eskens
, Casper van Eijck
, J.J.M.E. Nuyttens

Research output: Contribution to journal › Article › Academic › peer-review

54 Citations (Scopus)

Original language	English
Pages (from-to)	232-236
Number of pages	5
Journal	Radiotherapy and Oncology
Volume	155
DOIs	https://doi.org/10.1016/j.radonc.2020.11.006
Publication status	Published - Feb 2021

Research programs

EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.radonc.2020.11.006

Cite this

@article{693281a6919f4a34900fc25293afd494,

title = "A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome",

author = "MA Teriaca and M Loi and Mustafa Suker and Ferry Eskens and \{van Eijck\}, Casper and J.J.M.E. Nuyttens",

year = "2021",

month = feb,

doi = "10.1016/j.radonc.2020.11.006",

language = "English",

volume = "155",

pages = "232--236",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome

AU - Teriaca, MA

AU - Loi, M

AU - Suker, Mustafa

AU - Eskens, Ferry

AU - van Eijck, Casper

AU - Nuyttens, J.J.M.E.

PY - 2021/2

Y1 - 2021/2

UR - https://www.scopus.com/pages/publications/85097133917

U2 - 10.1016/j.radonc.2020.11.006

DO - 10.1016/j.radonc.2020.11.006

M3 - Article

C2 - 33217500

SN - 0167-8140

VL - 155

SP - 232

EP - 236

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

ER -

A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome

Research programs

UN SDGs

Access to Document

Other files and links

Cite this